735(top 1%)
papers
42.8K(top 0.1%)
citations
98(top 0.1%)
h-index
180(top 0.1%)
g-index
744
all documents
45.1K
doc citations
4.5K
citing journals

Top Articles

#TitleJournalYearCitations
1Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine20011,926
2Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast CancerNew England Journal of Medicine20061,317
3Association analysis identifies 65 new breast cancer risk lociNature20171,099
4Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trialAnnals of Oncology20141,022
5Risk stratification of patients diagnosed with gastrointestinal stromal tumorHuman Pathology2008977
6Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled TrialJournal of the National Cancer Institute1998862
753BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancersNature Structural and Molecular Biology2010846
8One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal TumorJAMA - Journal of the American Medical Association2012832
9Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC studyAnnals of Oncology2013792
10Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohortsLancet Oncology, The2012790
11Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 StudiesPLoS Medicine2010764
12A common coding variant in CASP8 is associated with breast cancer riskNature Genetics2007591
13Gastrointestinal stromal tumourLancet, The2013518
14Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer TrialJournal of Clinical Oncology2009406
15VEGF and angiopoietin signaling in tumor angiogenesis and metastasisTrends in Molecular Medicine2011391
16Genome-wide association studies identify four ER negative–specific breast cancer risk lociNature Genetics2013374
17Tumor doubling times in metastatic malignant melanoma of the uvea Tumor progression before and after treatmentOphthalmology2000334
18Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cellsNature Communications2015334
19Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapyGastroenterology2000322
20Adjuvant Clodronate Treatment Does Not Reduce the Frequency of Skeletal Metastases in Node-Positive Breast Cancer Patients: 5-Year Results of a Randomized Controlled TrialJournal of Clinical Oncology2001318
21Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological CharacteristicsPLoS Genetics2008315
22Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab TherapyJAMA Oncology2019295
23Vascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expressed in Human TumorsAmerican Journal of Pathology1998289
24Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerNature Genetics2017289
25Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised studyBritish Journal of Cancer2007287
26A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancerNature Genetics2011279
27Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 FamiliesJournal of Clinical Oncology2020270
28Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast GroupEuropean Journal of Cancer1999265
29Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analysesNature Genetics2020265
30Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapyBlood2007260
31A High Pretreatment Serum Vascular Endothelial Growth Factor Concentration Is Associated With Poor Outcome in Non-Hodgkin's LymphomaBlood1997240
32High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancerInternational Journal of Cancer1998232
33Gastrointestinal stromal tumor (GIST)Annals of Oncology2006230
34Gastrointestinal Stromal Tumors With KIT Exon 11 Deletions Are Associated With Poor PrognosisGastroenterology2006211
35HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature reviewBritish Journal of Cancer2004197
36KIT and Platelet-Derived Growth Factor Receptor Alpha Tyrosine Kinase Gene Mutations and KIT Amplifications in Human Solid TumorsJournal of Clinical Oncology2005195
37A High Tumor-Associated Macrophage Content Predicts Favorable Outcome in Follicular Lymphoma Patients Treated with Rituximab and Cyclophosphamide-Doxorubicin-Vincristine-PrednisoneClinical Cancer Research2007195
38Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head-and-Neck Cancer: Final Analysis of a Phase I/II TrialInternational Journal of Radiation Oncology Biology Physics2012192
39Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patientsActa Oncológica2004189
40A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancerNature Genetics2018184
41NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancerNature Genetics2008181
42PALB2,CHEK2andATMrare variants and cancer risk: data from COGSJournal of Medical Genetics2016174
43SMAD4 as a Prognostic Marker in Colorectal CancerClinical Cancer Research2005172
44Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumorsGenes Chromosomes and Cancer2010172
45Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factorClinical Cancer Research1999171
46Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic SymptomsJournal of Pain and Symptom Management2008168
47A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11Human Molecular Genetics2012168
48Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristicsBreast Cancer Research2010167
49Risk for Distant Recurrence of Breast Cancer Detected by Mammography Screening or Other MethodsJAMA - Journal of the American Medical Association2004165
50Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based studyClinical Cancer Research2003160